Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Zedsen Closes $12M Series B, Expands Team with Appointment of New CTO
Zedsen, a UK health tech company with a revolutionary non-invasive technology that helps consumers understand […]
Hawaii Cancer Care Deploys AI-Screening Tool VIPER ™
Hawaii Cancer Care and Deep Lens today announced a partnership that will expand the clinical trial offering for […]
Brii Biosciences (Brii Bio) Closes US$155 Million Series C Financing
Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet […]
Healx Using Artificial Intelligence to Find Combination Drug Treatments for Covid-19
Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its […]
Twice Weekly Rapid Testing to be Available to Everyone in England
Everyone in England will be able to access free, regular, rapid coronavirus testing from 9 […]
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Eloxx Pharmaceuticals, Inc. today announced it has acquired Zikani Therapeutics, Inc. in an all-stock transaction, with […]
Roche Launches Elecsys Epstein-barr Virus (Ebv) Immunoassay Panel
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Elecsys® EBV panel has launched […]
Huyabio International Collaboration with Bristol Myers Squibb in Melanoma
HUYABIO International (HUYABIO™), the leader in accelerating global development of China’s pharmaceutical innovations, today announced that it […]
Omega Therapeutics to Advance Pipeline and Platform Development with Additional Financing
Omega Therapeutics, Inc. (“Omega“), a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to […]
Lilly, Vir, GSK Announce Positive Topline Data from Phase 2 BLAZE-4 Trial
Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more